Screener
XPH vs XBI
State Street SPDR S&P Pharmaceuticals ETF vs State Street SPDR S&P Biotech ETF
Key differences
- XBI is significantly larger than XPH — larger funds tend to be more liquid and less likely to close.
- Over the last 3 years, XBI has delivered higher annualized returns.
Side-by-side comparison
| XPH | XBI | |
|---|---|---|
| Annual cost (TER) | 0.35% | 0.35% |
| Fund size (AUM) | $355M | $8.3B |
| Since | 2006 | 2006 |
| Dividend yield | 0.65% | 0.34% |
| Asset class | equity | equity |
| Region | north america | north america |
| Strategy | index tracking | index tracking |
| CAGR 1Y | +46.3% | +66.6% |
| CAGR 3Y | +13.8% | +15.6% |
| CAGR 5Y | +4.5% | +0.9% |
| Sharpe 3Y | 0.57 | 0.54 |
| Volatility 1Y | 21.29% | 25.14% |
| Max drawdown | -35.96% | -63.89% |
Green dot indicates the better value for that metric. Performance data is historical and does not predict future results.
Similar to XPH and XBI
Explore further